This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
Journal of Intellectual Property
  • Menu
  • Articles
    • General
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • search
  • X (formerly Twitter) (opens in a new tab)
  • Facebook (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:32003/feed
P-ISSN 2575-3819
E-ISSN 2575-3827
General
Vol. 19, Issue 1, 2011January 01, 2011 EDT

Placebo Patents: Creating Stronger Intellectual Property Protection for Pharmaceuticals Approved by the U.S. Food & Drug Administration

Sarah Renee Craig,
patentspharmaceutical patentsFDAmonopoly protectionEli Lilly v. Actavis Elizabeth LLCoff-label marketingincontestability doctrinepatent validityutilityHatch-Waxman ActInvestigational New Drug ApplicationBiotechnology Industry Organizationtrade secretsAbbreviated New Drug ApplicationBrenner v. MansonIn re Kimmelreasonable correlationInstitutional Review BoardFalse Claims Act
Journal of Intellectual Property
Sarah Renee Craig, Placebo Patents: Creating Stronger Intellectual Property Protection for Pharmaceuticals Approved by the U.S. Food & Drug Administration, 19 Journal of Intellectual Property 143 (2011).

View more stats

Powered by Scholastica, the modern academic journal management system